"What this collaboration will allow us to do is to have a member enter a pathway and answer questions to assess [the medications'] appropriateness," Gary Foster, Ph.D., WW's chief scientific officer, told "Good Morning America." "And then following that initial assessment, to connect with a clinical provider who can then determine with that individual which medications, if any, are the right path for them." Sequence currently costs $99 per month, and serves around 24,000 members across the United States
Overall, 14% (0.6 million) of the 4.2 million PDP enrollees receiving LIS in 2026 (excluding those in employer group plans) are enrolled in non-benchmark PDPs
Potential side effects of GLP-1s include nausea, vomiting, changes in vision, low blood sugar, and, in rare cases, thyroid cancer
Yes, peptide therapy should be administered under the supervision of a qualified healthcare professional
The funders had no role in the design of the study, in the collection, analysis, and interpretation of data, or in writing the manuscript